Atlas Trials

A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)

Clinical trial NCT04120415 · COMPLETED

Trial details

NCT number
NCT04120415
Sponsor
ANRS, Emerging Infectious Diseases
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV-1-infection
Start date
2022-06-21
Primary completion
2023-07-12
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.